| Literature DB >> 25049357 |
Silvia Bozza1, Silvia Campo2, Brunilde Arseni2, Antonio Inforzato2, Lindstedt Ragnar2, Barbara Bottazzi3, Alberto Mantovani3, Silvia Moretti1, Vasileios Oikonomous1, Rita De Santis2, Agostinho Carvalho1, Giovanni Salvatori2, Luigina Romani4.
Abstract
The long pentraxin 3 (PTX3) modulates different effector pathways involved in innate resistance to Aspergillus fumigatus, including complement activation or promotion of phagocytosis by interacting with FcγRs. However, whether and how TLRs modulate PTX3 mediates antifungal resistance is not known. In this study, we demonstrate that PTX3 binds myeloid differentiation protein 2 (MD-2) in vitro and exerts its protective antifungal activity in vivo through TLR4/MD-2-mediated signaling. Similar to Tlr4(-/-) mice, Md2(-/-) mice displayed high susceptibility to pulmonary aspergillosis, a phenotype associated with a proinflammatory cytokine profile and impaired antifungal activity of polymorphonuclear neutrophils. Treating Md2(-/-) mice with PTX3 failed to confer immune protection against the fungus, whereas adoptive transfer of MD-2-competent polymorphonuclear neutrophils restored it. Mechanistically, engagement of MD-2 by PTX3-opsonized Aspergillus conidia activated the TLR4/Toll/IL-1R domain-containing adapter inducing IFN-β-dependent signaling pathway converging on IL-10. Thus, we have identified a novel receptor mechanism, involving the TLR4/MD-2/Toll/IL-1R domain-containing adapter inducing IFN-β-mediated signaling, whereby PTX3 elicits antifungal resistance with limited immunopathology in A. fumigatus infection.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25049357 DOI: 10.4049/jimmunol.1400814
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422